Skip to content
GLP-1 Decoder

Mounjaro Long-Term Side Effects: What Years of Data Show

Mounjaro has been sold in the US since 2022. The long-term label warnings are thyroid C-cell tumors (seen in rodents), pancreatitis, gallbladder disease and kidney injury from fluid loss.

Sold in the US since
2022
Most common
Nausea 18%
Same on placebo
4%
Trial group
Adults with type 2 diabetes

A quick look at Mounjaro

How long it remains in the body
100%50%25%0%05 d10 d15 d20 d25 d50%25%12.5%time after the dose

Its half-life is about 5 days: after 5 d, half is gone, and after five half-lives (25 d), about 3% remains.

Weight loss in its main trial
Mounjaro (SURPASS-1)7.8 kgPlacebo1 kg

In the 40-week SURPASS-1 trial for type 2 diabetes, weight loss was 7.8 kg, compared with 1 kg on placebo.

Cost over time
2026$1,112.16$0List priceSelf-pay

Monthly US dollar prices include the list price and self-pay offers, all taken from the maker's price page.

Sources: FDA label (DailyMed), healthsystemtracker.org, pricinginfo.lilly.com.

Serious warnings, in plain words

Source: FDA label (DailyMed).

Source: FDA label (DailyMed).

Mounjaro long term side effects: label rates vs placebo

The FDA label lists 7 common Mounjaro side effects found in placebo-controlled trials. In the final column, you can see the amount by which each side effect appeared more often than with placebo.

Table 1: Adverse Reactions found in Pool of Placebo-Controlled Trials Reported in ≥5% of MOUNJARO-treated Adult Patients with Type 2 Diabetes Mellitus
Side effectPlaceboMounjaro 5 mgMounjaro 10 mgMounjaro 15 mgMore than placebo, 15 mg
Nausea4%12%15%18%+14 points
Diarrhea9%12%13%17%+8 points
Decreased Appetite1%5%10%11%+10 points
Vomiting2%5%5%9%+7 points
Dyspepsia3%8%8%5%+2 points
Constipation1%6%6%7%+6 points
Abdominal Pain4%6%5%5%+1 points

Source: FDA label (DailyMed).

Who experiences more side effects